Matches in Nanopublications for { ?s ?p "[Forodesine, a purine nucleoside phosphorylase inhibitor, displays in vitro activity in chronic lymphocytic leukemia (CLL) cells in presence of dGuo, which is the basis for an ongoing clinical trial in patients with fludarabine-refractory CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP751701.RA8StOvS1W6dzbGFm1g0yPD67Jy6q-HtaFpIvch6r_aNw130_assertion description "[Forodesine, a purine nucleoside phosphorylase inhibitor, displays in vitro activity in chronic lymphocytic leukemia (CLL) cells in presence of dGuo, which is the basis for an ongoing clinical trial in patients with fludarabine-refractory CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP751701.RA8StOvS1W6dzbGFm1g0yPD67Jy6q-HtaFpIvch6r_aNw130_provenance.
- NP597034.RAy0DYBYmt-x8BnO-PLagwfrERK03PtPG95yMiopIsWsk130_assertion description "[Forodesine, a purine nucleoside phosphorylase inhibitor, displays in vitro activity in chronic lymphocytic leukemia (CLL) cells in presence of dGuo, which is the basis for an ongoing clinical trial in patients with fludarabine-refractory CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP597034.RAy0DYBYmt-x8BnO-PLagwfrERK03PtPG95yMiopIsWsk130_provenance.
- NP810064.RA-gIJdEk2Yy6ASZZY0cPzkXqo3eTemPREXFnrCxMYgro130_assertion description "[Forodesine, a purine nucleoside phosphorylase inhibitor, displays in vitro activity in chronic lymphocytic leukemia (CLL) cells in presence of dGuo, which is the basis for an ongoing clinical trial in patients with fludarabine-refractory CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP810064.RA-gIJdEk2Yy6ASZZY0cPzkXqo3eTemPREXFnrCxMYgro130_provenance.
- assertion description "[Forodesine, a purine nucleoside phosphorylase inhibitor, displays in vitro activity in chronic lymphocytic leukemia (CLL) cells in presence of dGuo, which is the basis for an ongoing clinical trial in patients with fludarabine-refractory CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Forodesine, a purine nucleoside phosphorylase inhibitor, displays in vitro activity in chronic lymphocytic leukemia (CLL) cells in presence of dGuo, which is the basis for an ongoing clinical trial in patients with fludarabine-refractory CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.